- Home
- LPG vs ABSI Comparison
LPG vs ABSI Comparison
Compare LPG & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPG | ABSI |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LPG | ABSI |
|---|---|---|
| Price | $56.36 | $10.52 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $54.60 | $14.40 |
| AVG Volume (30 Days) | 534.4K | ★ 3.6M |
| Earning Date | 11-05-2026 | 11-11-2026 |
| Dividend Yield | ★ 5.12% | N/A |
| EPS Growth | ★ 112.15 | 10.64 |
| EPS | ★ 3.24 | N/A |
| Revenue | ★ $481,511,242.00 | $4,534,000.00 |
| Revenue This Year | $32.64 | $39.03 |
| Revenue Next Year | N/A | $310.91 |
| P/E Ratio | $17.82 | ★ N/A |
| Revenue Growth | ★ 36.27 | N/A |
| 52 Week Low | $23.76 | $2.24 |
| 52 Week High | $59.97 | $12.06 |
Technical Indicators
Market Signals| Indicator | LPG | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 59.35 | 56.11 |
| Support Level | $52.09 | $8.17 |
| Resistance Level | $59.97 | $11.66 |
| Average True Range (ATR) | 2.10 | 0.87 |
| MACD | -0.16 | 0.15 |
| Stochastic Oscillator | 54.95 | 64.35 |
Price Performance
Historical ComparisonAbout LPG Dorian LPG Ltd.
Dorian LPG Ltd is an international liquefied petroleum gas shipping company focused on owning and operating gas carriers, or VLGCs. The company currently owns and operates around 22 modern VLGCs, including nineteen new fuel-efficient 84,000 cbm ECO-design VLGCs. Dorian LPG has offices in Connecticut, USA, London, United Kingdom, and Athens, Greece. IT operates in one reportable segment, the international transportation of LPG.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.